Report overview
This report contains market size and forecasts of Congestive Heart Failure Drugs in global, including the following market information:
Global Congestive Heart Failure Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Congestive Heart Failure Drugs Market Sales, 2017-2022, 2023-2028, (K MT)
Global top five Congestive Heart Failure Drugs companies in 2021 (%)
The global Congestive Heart Failure Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injection Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Congestive Heart Failure Drugs include Sanofi, Novartis, Pfizer, Merck & Co, AstraZeneca, GSK, Bristol-Myers Squibb, Mylan and Bausch Health, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Congestive Heart Failure Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Congestive Heart Failure Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Congestive Heart Failure Drugs Market Segment Percentages, by Type, 2021 (%)
Injection
Capsule
Tablets
Global Congestive Heart Failure Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Congestive Heart Failure Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Household
Other
Global Congestive Heart Failure Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)
Global Congestive Heart Failure Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Congestive Heart Failure Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Congestive Heart Failure Drugs revenues share in global market, 2021 (%)
Key companies Congestive Heart Failure Drugs sales in global market, 2017-2022 (Estimated), (K MT)
Key companies Congestive Heart Failure Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Novartis
Pfizer
Merck & Co
AstraZeneca
GSK
Bristol-Myers Squibb
Mylan
Bausch Health
Johnson & Johnson
Bayer
Boehringer Inhelheim
Exelixis
Lunan Pharmaceutical
Sinepharm
CRC
Hai Ni Pharmaceutical
Langtian
NCPC
Hayao
Xinhua Group
Xudong Haipu Pharmaceutical
